Company Filing History:
Years Active: 2021
Title: Innovations of Feng-Ling Yang in Glycoconjugate Vaccines
Introduction
Feng-Ling Yang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in the area of glycoconjugate vaccines. His work focuses on innovative methods to combat bacterial infections caused by Gram-negative pathogens.
Latest Patents
Feng-Ling Yang holds a patent for a glycoconjugate vaccine, which includes a preparation method and its uses. The patent describes a glycoconjugate vaccine that provides protection against Gram-negative pathogen infections. The manufacturing method of this vaccine is also detailed, along with its application in treating bacterial infections. The structure of the glycoconjugate vaccine is defined by a formula where a maleimide-type linker connects to a carrier protein through a maleimide bond. The parameters n and m in the formula can vary between 2 and 20.
Career Highlights
Feng-Ling Yang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has been instrumental in advancing the understanding and development of vaccines, contributing to public health initiatives.
Collaborations
Feng-Ling Yang has collaborated with notable colleagues such as Shih-Hsiung Wu and Chung-Yi Wu. Their combined expertise has furthered research in the field of glycoconjugate vaccines.
Conclusion
Feng-Ling Yang's innovative work in glycoconjugate vaccines represents a significant advancement in the fight against bacterial infections. His contributions are vital for future developments in vaccine technology.